2025. Application of Nanocarrier-Based Targeted Drug Delivery in the Treatment of Liver Fibrosis and Vascular Diseases. Journal of Medicine and Life Sciences. 1, 2 (Apr. 2025), 63–69. DOI:https://doi.org/10.71222/bc9c9s73.